Row over SMA drug distribution in Keralam unwarranted, say experts
Solo lo publica The Hindu: sin contraste todavía
Ningún otro medio de los que seguimos ha contado esta noticia, así que no hay versiones que comparar. Si otros la publican o aparecen datos que la contrasten, pasará a la comparativa.
SAT Hospital authorities deny the claim of parents of SMA children that the drug given free of cost at the hospital clinic was an “experimental drug.” Hospital authorities say what was given was the generic version of Risdiplam, the patented original formula by Roche, now manufactured by the Indian firm Natco Pharma and which has been approved by drug regulatory bodies in the country
Ficha de captura
- Fuente
- https://www.thehindu.com/news/national/kerala/row-over-sma-drug-distribution-in-keralam-unwarranted-say-experts/article71607610.ece
- Publicado
- 21/10/2026 18:35 UTC
- Capturada
- 22/10/2026 01:39 UTC
- Huella del texto
ab0f4a724bb265c8· 696 palabras- Cambios detectados
- 0
- Copia de archivo
- Wayback Machine ↗